Study questions long-term ADHD med use; Osiris ends trial enrollment;

> New data from a big federal study of ADHD meds appears to show that long-term use of the drugs isn't very helpful, and may even be harmful. This, after initial results from the study--reported back in 1999--overwhelmingly supported drug therapy as a better treatment option than talk therapy or routine medical care alone. FiercePharma

> Osiris Therapeutics has ended enrollment in a late-stage trial of Prochymal for Crohn's disease, saying that it believes that a design flaw spurred an unexpected placebo response. FierceBiotech

> A growing number of researchers are turning to dogs to take the place of mice in animal cancer studies. Dogs, they say, are innately superior to mice as a treatment subject, because they develop cancer spontaneously, unlike the genetically crafted mice, and dogs are also genetically more of a match for humans. FierceBioResearcher

And Finally... Way to lead by example, chief! Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.